par 166 (Benztropine 2 mg)
Pill imprint par 166 has been identified as Benztropine mesylate 2 mg.
Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 166 (Benztropine 2 mg)
- 2 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00182-1701||Goldline Laboratories Inc|
|63739-0035||McKesson Packaging Services|
|68115-0044||Dispensexpress Inc (repackager)|
|66336-0699||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Benztropine mesylate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...